Biomedical, Clinical & Life Sciences

No Applicants // Limit: 1 // Tickets Available: 1 

These grants fund new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with highrisk cancers. This Grant is given to single or multi-institutional programs that involve open, cancer clinical trials or consortia, and implement new approaches to therapy. Applicants must be a PhD and/or MD.

Limit:1 // E. Thornley (College of Medicine -Phoenix) 

These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future.

No Applicants  //  Limit: 1 // Tickets Available: 1 

These grants fund basic science, translational and/or clinical state of the art pediatric cancer research initiatives. These grants fund work that is the basis for childhood cancer research, helping to move science in the direction of improved treatments and eventually finding a cure. They are designed to move hypothesis-driven research into the clinic providing support for important preclinical projects that are necessary to move a study from the pre-clinical arena into a clinical trial. Applicants must be a PhD (with a least two years as a junior faculty or assistant professor) and/or MD

No Applicants  // Limit: 1 // Tickets Available: 1 

An institution may submit only one Partner Hub (and related Projects) proposal or one Community Engagement Resource Center proposal. There are two (2) funding opportunities through this unique award mechanism; an individual may apply for only one of these opportunities:

1. Health Equity Research Network (HERN) on Community-Driven Research Approaches – Partner Hub
   Required pre-proposals due by Tuesday, March 26, 2024
   The key outcome of this HERN is the establishment of new models for community-driven research that can be scaled and used as a foundation for shifting norms, paradigms and practices within all domains of health research. Each Partner Hub must have two research projects and be represented by a community-based organization and an academic institution. The collaborations between and among the Partner Hubs build momentum around both systems change and knowledge of a particular issue, making it an ideal mechanism to meet the interrelated objectives.  
    
2. Health Equity Research Network on Community-Driven Research Approaches – Community Engagement Resource Center
   Required pre-proposals due by Thursday, March 28, 2024
   The Community Engagement Resource Center (CERC) will, under leadership of the Director, incorporate a multidisciplinary approach to provide capacity building, training, evaluation, and the management of a Community of Practice for the full Network. The CERC will facilitate engagement across the Partner Hubs and service as a coordinating center, facilitating capacity building, study optimization, communication, evaluation, and a Community of Practice. 

This funding mechanism will establish a collaborative, multi-center network with a specific focus on innovative methodological approaches for community-driven research and developing new scalable models for doing research differently, with greater shared authority with CBOs. The Network will create, implement, and make available to the broader scientific community a body of evidence- driven approaches that will support academic and community-based partners in working as equal partners to conduct research that meets the needs of the local community.  Specific deliverables will include a “playbook” of best practices for community-driven research and a compendium of published materials and key outcomes.  In addition, through opportunities provided to the program the training of trainees, this mechanism will help to develop the next generation of researchers and CBO staff who are experienced in working collaboratively to promote the health and well-being of all individuals in their communities.

No Applicants // Limit: one postdoctoral applicant per lab

The Predoctoral Fellowship in Drug Discovery Targets and Pathways provides support for promising students in advanced stages of training and thesis research in drug discovery research.

Eligibility: 

• Applicants will have completed most of their pre-thesis requirements and be PhD candidates. 
• Applicants should expect to complete their PhD requirements in two years or less from the time funding begins. 
• Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active. 

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

No Applicants   // Limit: one postdoctoral applicant per lab

The PhRMA Foundation seeks to fund novel early-stage, exploratory drug discovery research with the potential for translation to humans, including biological validation of potential drug targets, signaling pathways, or mechanisms of disease. 

Eligibility:

• Applicants must hold a PhD, PharmD, MD, before funding can begin.
• Applicants must be within their first five years of postdoctoral study at the time of award activation.

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

No Applicants  // Limit: one postdoctoral applicant per lab

The Predoctoral Fellowship in Drug Delivery provides support for promising students in advanced stages of training and thesis research in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility: 

• Applicants will have completed most of their pre-thesis requirements and be PhD candidates. 
• Applicants should expect to complete their PhD requirements in two years or less from the time funding begins. 
• Applicants enrolled in MD/PhD programs should not be engaged in required clinical coursework or clerkships while the fellowship is active. 

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

No Applicants // Limit: one postdoctoral applicant per lab

The Postdoctoral Fellowship in Drug Delivery supports individuals engaged in a multidisciplinary, collaborative research training program that will extend their credentials in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility:

• Applicants must hold a PhD, PharmD, MD, before funding can begin.
• Applicants must be within their first five years of postdoctoral study at the time of award activation.

*Due to the competitive nature of this funding program, the internal competition is run based on the anticipated May 15, 2024 LOI deadline.

Limit: 1 //  S. Radovick ( Health Sciences)

The National Center for Advancing Translational Sciences (NCATS) will award Institutional Research Career Development (K12) programs through the Clinical and Translational Science Awards (CTSA). The purpose of this Funding Opportunity Announcement (FOA) is to encourage institutions to propose creative and innovative institutional research career development programs designed to prepare an outstanding heterogeneous pool of promising later stage postdoctoral fellows and junior faculty scholars in clinical and translational science who have made a commitment to independent research careers (i.e., tenure-track or equivalent faculty positions), and to facilitate their timely transition to more advanced support mechanisms, e.g., K08, K23, R01, R03, etc. Applicants must submit both a UM1 application to PAR-21-293: Clinical and Translational Science Award and a K12 application to this FOA.

This Funding Opportunity Announcement (FOA) allows appointment of Scholars (K12) proposing to serve as the lead investigator of an independent clinical trial; or proposing a separate ancillary clinical trial; or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

With this solicitation for the K12 application, a separate, companion FOA solicits applications for a required UM1 (PAR-21-293). A UM1 hub application without the required companion K12 application will not be reviewed. The required K12 application will only be awarded if the UM1 application is awarded. Initial and resubmission of K12 will be accepted concurrently or if the UM1 application is awarded.

The application must provide a specific plan describing the partnership between the UM1, the required K12 and any optional components. The applicant institution must be the UM1 applicant. The UM1 institution must have a strong and high-quality research program in the area(s) proposed under this K12 FOA and must have the requisite faculty, staff, potential scholars and facilities on site to conduct the proposed institutional program. In many cases, it is anticipated that the proposed program will complement other ongoing career development programs occurring at the applicant institution and that a substantial number of program faculty will have active research projects in which participating scholars may gain relevant experiences consistent with their research interests and goal.

The sponsoring institution must assure support for the proposed program. Appropriate institutional commitment to the program includes the provision of adequate staff, facilities, and educational resources that can contribute to the planned program.

The PD/PI should be an established investigator in the scientific area in which the application is targeted and capable of providing both administrative and scientific leadership to the development and implementation of the proposed program. The PD/PI will be responsible for the selection and appointment of trainees to the approved research training program, and for the overall direction, management, administration, and evaluation of the program. The PD/PI will be expected to monitor and assess the program and submit all documents and reports as required. The PD/PI has responsibility for the day to day administration of the program and is responsible for appointing members of the Advisory Committee (when applicable), using their recommendations to determine the appropriate allotment of funds.

Only one K12 application will be awarded if the UM1 application is awarded. If the UM1 is awarded and the initial K12 is not, the K12 application may be resubmitted. If the UM1 (A0) application is not awarded, then the K12 (A0) will not be awarded.

NCATS solicits the submission of one set of companion applications. With this FOA for the K12 application, a separate, companion FOA seeks applications for a required UM1 (PAR-21-293: Clinical and Translational Science Award). The UM1 and initial K12 applications must be submitted concurrently; a K12 application without the required companion UM1 application will not be reviewed. The required K12 application will only be awarded if the UM1 application is awarded. 

Limit: 1 // S. Carvajal (Health Promotion Sciences /Arizona Prevention Research Center (AzPRC)).

Only one application per SIP per institution is allowed (e.g., multiple applications for the same SIP from the same institution are NOT permitted).

This Notice of Funding Opportunity (NOFO) will provide supplemental funding to the CDC Health Promotion and Disease Prevention Research Centers (RFA-DP-24-004) to conduct Special Interest Research Projects (SIP) to inform public health practice. Recipients will conduct high-quality applied health promotion and disease prevention research in real-world settings to identify, design, test, assess, evaluate, disseminate, and translate interventions (i.e., programs, practices, policies, or strategies) to prevent and reduce risk for the leading causes of illness, disability, and death in the United States.

Competition is limited to the 20 institutions approved for funding under CDC RFA-DP-24-004 as CDC Prevention Research Centers (PRCs). The institutions currently approved for funding are:
U48 DP006799 University of Arizona PI:  S. Carvajal